Added to YB: 2018-08-02
Pitch date: 2018-08-02
SCYX [bullish]
SCYNEXIS, Inc.
-95%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
SCYNEXIS, Inc., a biotechnology company, engages in drug development for the treatment and prevention of difficult-to-treat and drug-resistant fungal infections in the United States.
Market Cap
$65.5M
Pitch Price
$14.20
Price Target
N/A
Dividend
N/A
EV/EBITDA
-0.35
P/E
-1.69
EV/Sales
0.41
Sector
Pharmaceuticals
Category
N/A
Show full summary:
SCYNEXIS INC SCYX
A summary for this pitch has not been created yet.
Read full article (0 min)